NSE: NIFTYMIDCAP50

16603.25 120.35 (0.73%)

Near 52W High of ₹17066.75

NSE 14 Jul, 2025 12:29 PM (IST)

Nifty Midcap 50 PB	5.5
Nifty Midcap 50 PE	39.9
Nifty Midcap 50 DIV	0.8
Nifty Midcap 50 EPS	413.3

Nifty Midcap 50 News and Updates

Name: Latest research reports of Aurobindo Pharma Ltd. authored by Geojit BNP Paribas and published by - Trendlyne research reports.
Item: Aurobindo Pharma Ltd.
Rating: 5
Author: Geojit BNP Paribas

Keep track of all breaking news on Nifty Midcap 50 from all sources in a single place.

Load latest

Is Nifty Midcap 50 worth buying?

81 Votes:

Buy 62.96%

Sell 23.46%

Hold 13.58%

Near 52W High of ₹17066.75

Nifty Midcap 50 PB

Nifty Midcap 50 PE

Nifty Midcap 50 DIV

Nifty Midcap 50 EPS

Nifty Midcap 50 News and Updates

Keep track of all breaking news on Nifty Midcap 50 from all sources in a single place.